Neuraxis NRXS
NYSE NRXS
$6.15 -0.12 (-1.91%)
At close: Aug 21, 2026 · 4:00 PM EDT

Neuraxis (NRXS) Gross Profit (2022 - 2025)

Neuraxis (NRXS) posted Gross Profit of $826476.0 for Q4 2025, up 22.27% sequentially from $675927.0 in Q3 2025, and up 25.97% YoY from $656112.0 in Q4 2024.

Neuraxis (NRXS) Gross Profit (2022 - 2025) Analysis & Trends

Neuraxis has reported Gross Profit for 4 years, with the latest figure at $826476.0 in Q4 2025.

  • Quarterly Gross Profit rose 25.97% year-over-year to $826476.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.0 million (up 28.72% YoY) and the FY2025 annual result came in at $3.0 million, up 29.37% from the prior year.
  • Gross Profit improved to $826476.0 in Q4 2025 per NRXS's latest filing, from $675927.0 in the prior quarter.
  • Over five years, Gross Profit peaked at $826476.0 in Q4 2025 and troughed at $410173.0 in Q3 2023.
  • A 4-year average of $612708.1 and a median of $578208.0 in 2023 frame the typical range for Gross Profit.
  • The sharpest annual moves came in 2023 and 2024: Gross Profit dropped 25.58% in 2023, then surged 42.91% in 2024.
  • Over 4 years, Gross Profit stood at $537868.0 in 2022, then fell by 14.64% to $459114.0 in 2023, then soared by 42.91% to $656112.0 in 2024, then advanced by 25.97% to $826476.0 in 2025.
  • According to Business Quant data, Gross Profit over the past three periods registered $826476.0, $675927.0, and $747443.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Neuraxis 74.54 Mn 66.21 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 826,476.00
Dec 31, 2025 826,476.00
Sep 30, 2025 675,927.00
Sep 30, 2025 675,927.00
Jun 30, 2025 747,443.00
Jun 30, 2025 747,443.00
Mar 31, 2025 756,180.00
Mar 31, 2025 756,180.00
Dec 31, 2024 656,112.00
Dec 31, 2024 656,112.00
Sep 30, 2024 569,575.00
Sep 30, 2024 569,575.00
Jun 30, 2024 538,042.00
Jun 30, 2024 538,042.00
Mar 31, 2024 571,554.00
Mar 31, 2024 571,554.00
Dec 31, 2023 459,114.00
Dec 31, 2023 459,114.00
Sep 30, 2023 410,173.00
Sep 30, 2023 410,173.00